Divis Laboratories Sees Surge with 7,266 Active Call Options at Rs 7,000 Strike
Divis Laboratories Ltd has become one of the most actively traded stocks, with significant call contract activity and a new 52-week high reached. Despite a decline in investor participation, the stock shows strong performance metrics and remains liquid, indicating resilience in a fluctuating market environment.
Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today. The company’s underlying asset, DIVISLAB, has seen significant trading activity, with 7,266 call contracts exchanged, resulting in a turnover of approximately Rs 1,426.39 lakhs. The options have an expiry date set for July 31, 2025, with a strike price of Rs 7,000 and an open interest of 2,286 contracts.Today, Divis Laboratories reached a new 52-week high of Rs 7,071.50, reflecting a 2.66% increase from the previous close. The stock has outperformed its sector by 1.9%, showcasing its resilience in a challenging market environment. Notably, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.
Despite this positive performance, there has been a notable decline in investor participation, with delivery volume dropping by 82.8% compared to the 5-day average. However, the stock remains liquid enough for trades up to Rs 4.11 crore, based on 2% of the 5-day average traded value. Overall, Divis Laboratories continues to demonstrate robust performance metrics amidst fluctuating market conditions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
